You are here
Chemesis Rolling Up High Value Cannabis Assets in United States -- CFN Media
SEATTLE, Oct. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Chemesis International Inc.'s (CSE: CSI) roll-up strategy in the crucial California cannabis industry. Through a series of acquisitions, Chemesis now is positioned in the state with fully licensed facilities and brands focused on the highest value segments of the market.
As the United States lurches toward potential legalization of cannabis, companies looking for a place in the market are focused on the most lucrative legal markets in hopes of creating a business model that can eventually be replicated across the country. California is clearly the prized market, and that state’s legalization has been a bit of a mess as the state navigates a complicated transition from a mix of black market and legal medical operations to an industry that is fully regulated throughout the state.
Chemesis’ 80%-owned subsidiary SAP Global operates a fully licensed production facility in Cathedral City, California. At full production, the factory can put out 200 pounds of clean, consistent cannabis oil daily. On top of the interest in the production facility, Chemesis fully owns the California Sap line of retail cannabis-based products. The product line includes award-winning CO2 extracts, the innovative Gramqul packaging system for cannabis oil, and a line of vaporizers.
In addition to its own line of products, SAP Global offers contract manufacturing of cannabis-derived products and white label production capabilities. This focus on extracts and associated products is central to Chemesis’ strategy in California. Industry-wide, consumer preferences are moving away from smoked flower and toward oils, concentrates, and alternative delivery methods that rely on extracts. On top of this trend, dried flower prices tend to drop significantly as legal markets mature, trimming margins for cultivators as the product becomes commoditized. To that end, Chemesis has chosen for the time being to not pursue cultivation assets in the state.
To complement its licensed production assets, Chemesis has acquired 100% of Desert Zen Fulfillment, a fully licensed cannabis manufacturing, packaging, and distribution operation based as well in Cathedral City, California. Desert Zen currently distributes a wide variety of products throughout the state. Its proximity to the SAP Global operations provides Chemesis a fully integrated operation in the Coachella Valley, one of the leading California regions in terms of creating a state-friendly regulatory environment for legal cannabis companies.
With an eye on lucrative international markets, Chemesis recently announced the opening of a wholly owned subsidiary called Chemesis Latin America. Reflective of Chemesis’ long term international growth strategy, the name of the subsidiary says it all in terms of market focus. Colombia, Peru, Chile, and Argentina all have recently passed medical cannabis laws, and Uruguay is the first country to decriminalize all drugs. Recognizing the potential of the market, Chemesis is actively seeking accretive opportunities there.
Chemesis is also looking to capitalize on another major trend in the cannabis industry. With investments pouring in to the emerging cannabis beverage sector, the company announced its intentions to develop and distribute cannabis beverages for both wholesale and retail markets. Leveraging the company’s production and distribution capabilities in Southern California, Chemesis anticipates launching initial products there in Q1 2019.
Chemesis is anticipating revenues in the neighborhood of $27 million in the first full year of its California operations, producing a projected net income of about $8 million. Should the company execute on these projections, they would represent impressive financial accomplishments in an industry built, to this point, largely on potential. Keep an eye out for further developments as Chemesis executes on its comprehensive strategy, both in the US and internationally.
Please follow the link to read the full article: http://www.cannabisfn.com/chemesis-rolling-high-value-cannabis-assets-united-states/
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/featuredcompany
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/